Douglas A. Roeder - May 27, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Douglas A. Roeder
Stock symbol
TNDM
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 07:28 PM
Previous filing
May 28, 2021
Next filing
Jun 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1.89K $0.00 1.89K May 27, 2021 Direct
holding TNDM Common Stock 990K May 27, 2021 See Footnote F1
holding TNDM Common Stock 9.67K May 27, 2021 See Footnotes F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1.89K -100% $0.00* 0 May 27, 2021 Common Stock 1.89K Direct F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.
F2 The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein.
F3 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F4 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F5 This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.
F6 RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.